Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2004
11/24/2004CN1549822A Methylene-4-azasteroids
11/24/2004CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004CN1549734A Aromatase inhibition to enhance assisted reproduction
11/24/2004CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004CN1549703A 药物输送体系 Drug delivery system
11/23/2004US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004CA2171329C Androstenones
11/23/2004CA2059052C Phenylimidazolidines, process for their preparation, their application as medicaments and pharmaceutical compositions containing them
11/18/2004WO2004099395A2 A method for the generation of neural progenitor cells
11/18/2004WO2004099122A2 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents
11/18/2004WO2004098646A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
11/18/2004WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
11/18/2004US20040229912 Polymeric delivery formulations of leuprolide with improved efficacy
11/18/2004US20040229899 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
11/18/2004US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004US20040229869 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma
11/18/2004US20040229823 For use in therapy of growth metabolic disorders
11/18/2004CA2524474A1 Methods of hormonal treatment utilizing extended cycle contraceptive regimens
11/18/2004CA2523712A1 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents
11/17/2004EP1477483A1 Vitamin d3 derivatives and remedies using the same
11/17/2004EP1477178A2 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/17/2004EP1476470A1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
11/17/2004EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004EP1171120A4 Methods for alleviating discomfort of a hot flash and compositions therefor
11/17/2004EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004EP1137667B1 Analogues of glp-1
11/17/2004EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004EP0731811B1 Chaperonin 10
11/17/2004CN1175827C Health-care Chinese traditional medicine, and method for preparing same
11/16/2004US6818638 Melvinolin derivatives
11/16/2004US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/11/2004WO2004096851A1 Galectin 9-inducing factor
11/11/2004WO2004096265A1 Nutrient liquid containing human growth hormone and the preparation method thereof
11/11/2004WO2004096250A1 Blood sugar regulating agent comprising a natural dry product derived from soya bean seeds alone or in a mixture and preparation thereof
11/11/2004WO2004096240A1 Anthocyanins useful for the treatment of diabetes, cardiovascular disorders and to lower the risk of adverse effects of hormone replacement therapy
11/11/2004WO2004096198A1 Therapeutic agent
11/11/2004WO2004096118A2 Composition for improving cognition and memory
11/11/2004WO2004072044A3 Urea and thiourea derivatives
11/11/2004WO2004028516A3 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases
11/11/2004WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004US20040225139 a 3-oxo-androstrane carbothioic acid compound
11/11/2004US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004US20040224934 3 -oxo-androstrane carbothioic acid compound
11/11/2004US20040224932 crystal structure; antiinflammatory agents; antiallergens
11/11/2004US20040224931 3-oxo-androstrane carbothioic acid compound
11/11/2004US20040224929 Novel vitamin D analogs
11/11/2004US20040224911 Transporters and ion channels
11/11/2004US20040224314 G-protein coupled receptors
11/11/2004US20040224018 labile agent such as human growth hormone complexed with zinc for example; wet milling suspension of labile agent dispersed in biocompatible polymer and solvent to submicron particles of labile agent; drying to form solid polymer/labile agent matrix; sustained release formulation
11/11/2004DE10317528A1 Production of calystegines for use as glycosidase inhibitors in treating diseases such as cancer, viral infections and diabetes, comprises extraction from the leaves of Solanaceae plants
11/11/2004CA2562863A1 Blood sugar regulating agent comprising a natural dry product derived from soya bean seeds alone or in a mixture and preparation thereof
11/11/2004CA2523508A1 Galectin 9-inducing factors
11/10/2004EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004EP1474122A2 Compounds for blocking androgen receptors
11/10/2004EP1474119A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
11/10/2004EP1474103A1 Levothyroxine compositions and methods
11/10/2004EP1474093A2 Granzyme b inhibitors
11/10/2004EP1280803B1 Crystalline form ii of cabergoline
11/10/2004EP0975348B1 Stabilized tibolone compositions
11/10/2004CN1545415A Bone anabolic compounds and methods of use
11/10/2004CN1545408A Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
11/10/2004CN1174969C New preparation method for N-(1, 1-dimethyl ethide)-4-[[(5'-oxethyl-4-cis-[2-(4-morpholino) oxethyl]-2'-oxo ancylus [cyclohexane-1, 3'-[3H] indole]-1'(2'H) group)-sulfonyl]-3-methoxyl benzamide and it
11/10/2004CN1174964C Vitamin D3 Analogs
11/09/2004US6815534 Tissue plasminogen activator-like protease
11/09/2004US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004US6814976 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
11/04/2004WO2004093882A1 Remedies for diseases to be applied to eye
11/04/2004WO2004093857A1 Composition for relieving unpleasant symptoms accompanying change in protesterone
11/04/2004WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004WO2003077847A3 Substituted amides
11/04/2004WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives
11/04/2004US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/04/2004US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004US20040220157 a 3-oxoandrostrane carbothioic acid compound
11/04/2004US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds,
11/04/2004US20040220092 G-protein coupled receptors